Bioprinting is coming of age: report from the International Conference on Bioprinting and Biofabrication in Bordeaux (3B'09)
Year: 2010
Type: article
Abstract: The International Conference on Bioprinting and Biofabrication in Bordeaux (3B'09) demonstrated that the field of bioprinting and biofabrication continues to evolve. The increasing number and broadening geography of participants, the emergence of new exciting bioprinting technologies, and the attraction of young investigators indicates the strong growth potential of this emerging field. Bioprinting can be defined as the use of computer-aided transfer processes for patterning and assembling living and non-living materials with a prescribed 2D or 3D organization in order to produce bio-engineered structures serving in regenerative medicine, pharmacokinetic and basic cell biology studies. The use of bioprinting technology for biofabrication of in vitro assay has been shown to be a realistic short-term application. At the same time, the principal feasibility of bioprinting vascularized human organs as well as in vivo bioprinting has been demonstrated. The bioprinting of complex 3D human tissues and constructs in vitro and especially in vivo are exciting, but long-term, applications. It was decided that the 5th International Conference on Bioprinting and Biofabrication would be held in Philadelphia, USA in October 2010. The specially appointed 'Eploratory Committee' will consider the possibility of turning the growing bioprinting community into a more organized entity by creating a new bioprinting and biofabrication society. The new journal Biofabrication was also presented at 3B'09. This is an important milestone per se which provides additional objective evidence that the bioprinting and biofabrication field is consolidating and maturing. Thus, it is safe to state that bioprinting technology is coming of age. 1. Back to Europe The International Conference on Bioprinting and Biofabrication in Bordeaux (3B'09), France, 6–8 July 2009, was held after several international meetings which had been organized previously. The First International Workshop on Bioprinting and Biopatterning [ 1 ] was held at the University of Manchester (UK) in September 2004 and was organized by Professor Brian Derby (University of Manchester), Douglas B Chrisey (Naval Research Laboratory, Washington, USA), Richard K Everett (ONR Global, London) and Nuno Reis (Universidade de Beira Interior, Covilha, Portugal). The Second International Workshop on Bioprinting, Biopatterning and Bioassembly was chaired by Vladimir Mironov in 2005 in Charleston (USA) [ 2 ]. The Third International Symposium on Bioprinting and Biofabrication was held in Kawasaki (Japan) in November 2006 and was organized by Professor Makoto Nakamura (University of Toyama, Japan). After three years without an international meeting, Fabien Guillemot (INSERM, University of Bordeaux, France) and Professor Makoto Nakamura decided to organize the International Conference on Bioprinting and Biofabrication (3B'09) [ 3 ] in Bordeaux, the wine capital of the world. This 4th international meeting on bioprinting was endorsed by TERMIS (Tissue Engineering and Regenerative Medicine International Society) and sponsored by the clusters Advanced Materials in Aquitaine, Materials in Bordeaux and Route des Lasers , INSERM and the Aquitaine Regional Council. It took place at the Burdigala Hotel in a very pleasant and friendly atmosphere where new players, especially the young, were welcome and were given the opportunity to discuss their work. The balanced geographical representation was another important feature of the 3B'09 conference. Indeed, more than 65 scientists and engineers from 11 countries (Belgium, France, Germany, Italy, Japan, Poland, Portugal, Romania, The Netherlands, UK, USA) attended this conference, which included five oral presentation sessions, one poster session and social events organized at the Bordeaux City Hall and at the Château Giscours. 2. Scientific program The scientific program was established to highlight the latest developments associated with bioprinting technologies and biofabrication approaches. Indeed, since the early pioneering works of Thomas Boland (Clemson University, USA) and Vladimir Mironov [ 4 ], the bioprinting scientific community has been evolving, bringing together physicists, biologists and physicians [ 5 , 6 ]. Consequently, the oral presentation sessions covered: (1) the latest developments in bioprinting technologies; (2) the potential to combine the bioprinting process with other biofabrication and rapid prototyping methods; (3) matrices and biomaterials for bioprinting and biofabrication; (4) methods for designing, modeling and biomechanically evaluating 3D constructs; (5) developmental biology and tissue engineering. This scientific schedule emphasized some of the main areas that have to be connected prior to envisaging real applications in regenerative medicine, pharmacokinetic and toxicological studies, where high throughput and high-resolution bioprinting technologies are required. Thus, it is now obvious that, in addition to core bioprinting technologies, biomaterial and bioink properties, rapid prototyping approaches and basic cell biology have to be taken into account within a single perspective. Consequently, while the initial definition of our burgeoning field was formulated at the First International Workshop on Bioprinting and Biopatterning in Manchester (UK) as 'the use of material transfer processes for patterning and assembling biologically relevant materials, molecules, cells, tissues, and biodegradable biomaterials with a prescribed organization to accomplish one or more biological functions', we propose to enlarge this definition to 'the use of computer-aided transfer processes for patterning and assembling living and non-living materials with a prescribed 2D or 3D organization in order to produce bio-engineered structures serving in regenerative medicine, pharmacokinetic and basic cell biology studies'. Regarding the poster session, three young scientists were awarded a bottle of Château Giscours wine for their impressive work. Laureates were Virginie Kériquel in vivo high-throughput biological laser printing of nano-hydroxyapatite in mice calvaria critical sized defects: preliminary results) [ 7 ], Kayo Sakaue (Integration of 3D-micro tissue models for creation of tissue chip) [ 8 ] and Alberto Rainer (Regeneration of osteochondral segment via mesenchymal stem cells culturing on 3D rapid prototyped scaffolds) [ 9 ]. 3. On bioprinting technologies The 3B'09 conference was an excellent opportunity to perform an in-depth review of bioprinting technologies (jet-based and extrusion methods) through a number of exciting talks given by both academics and industrialists. Recent advances in ink-jet bioprinting technologies were reviewed by Professor Thomas Boland and supplemented mainly by the presentations given by Professor Makoto Nakamura [ 10 , 11 ] and Professor Brian Derby. Regarding laser-based technologies, a series of talks dealing with experimental and modeling approaches of laser-assisted bioprinting (LAB) [ 12 ] were given by members of Fabien Guillemot [ 13 ] and Boris Chichkov's groups [ 14 ] from The University of Bordeaux and Lazer Zentrum in Hannover (Germany), respectively. Utkan Demirci (Harvard University, USA) introduced a new ultrasonic wave-based bioprinting technology, the so-called layer-by-layer 3D tissue epitaxy by cell-laden hydrogel droplets [ 15 ] while Hedges and Wirth from Germany presented an aerosol jet bioprinting technology and its applications in surface biofunctionalization [ 16 ]. Besides the above-mentioned jet-based bioprinting techniques, many presentations were related to 3D plotting by extrusion processes. Giovani Vozzi's group (University of Pisa, Italy) presented several talks dealing with the micro-fabrication of two- and three-dimensional structures by pressure-assisted micro-syringe (PAM) [ 17 ]. Moreover, processing considerations for the 3D plotting of thermoplastic scaffolds were presented by Kim Ragaert (Ghent University, Belgium) [ 18 ] and Hendrik John (Sys-Eng, Germany) while Kentaro Iwami (Tokyo University, Japan) described for the first time rapid prototyping by extruding/aspirating/refilling thermoreversible hydrogel [ 19 ]. Finally, additional 3D biofabrication methods were presented. Matsusaki et al (Japan) introduced possible, layer-by-layer, short-term applications of bioprinting for biofabrication of tissue chips. Frasca et al (University of Paris-Diderot, France) demonstrated how nanotechnology (magnetic nanoparticles) can be employed in magnetic force-driven tissue engineering. In summary, while each of these technologies displays specific properties such as high resolution, high throughput, low price, bio-safety, etc, it seems obvious that achieving more advanced applications in tissue engineering will require a combination of these tools, and thus a combination of their performances. Moreover, to print human organs, highly integrative approaches should be set up; these should include the development of new biomaterials, the improvement of reverse-engineering and rapid prototyping methods, intensification of scientific gateways between developmental biology and tissue engineering [ 20 ] (as introduced by Gabor Forgacs, University of Missouri, USA) [ 21 ], in particular with the help of numerical modeling. All these perspectives were discussed during the conference and are reported in the following sections. 4. Scaffold or not scaffold, that is the question! One of the controversial topics of discussion during the conference was the definition of 'scaffold'. Synthetic biodegradable scaffold is considered to be a fundamental principle of the traditional scaffold-based or 'top down' tissue engineering approach [ 22 ]. The emerging modular or 'bottom-up' approach is sometimes called 'scaffold-free' [ 23 ] or 'scaffold-less'. Some participants insisted that scaffold according to definition is a temporal and removable support. Thus, using the term 'scaffold-less' when in reality a 'temporal supporting template' (for example, agarose hydrogel) has been used, is debatable. If in bioprinting technology, biodegradable, removable or sacrificial hydrogel is used, then the term 'scaffold-less' becomes even more inappropriate. Consequently, whether bioprinting is in essence a bottom-up approach, and thus differs from traditional scaffold-based tissue engineering, it does not imply necessarily that it is scaffold-less. Hence, 'solid scaffold-free' is probably a more justifiable term than 'scaffold-less'. It does not however exclude the possibility of developing scaffold-less bioprinting based on using only cellular material without any temporal or supporting scaffold or hydrogels (biopapers). It has already been proven that an engineering vascular graft using synthetic scaffold-free cell sheet technology is feasible [ 24 ]. But even in this case, a so-called 'internal membrane' has been used which is nothing more that a decellularized extracellular matrix (or scaffold) synthesized by living cells in vitro . It is debatable whether fast-evolving self-assembly technology and the generation of self-assembling natural-like or biomimetic extracellular matrices using methods of macromolecular chemistry and nanotechnology will make the difference between scaffold-less and scaffold based bioprinting technology even more fuzzy. Thus, it remains to be seen if 'solid scaffold-free' or 'scaffold-less' bioprinting technology is just semantic or a real innovation. In addition to mechanical support and biological uses, it was shown during the conference that scaffolds could bring additional signals. Vozzi's group (University of Pisa, Italy) demonstrated such an approach in designing novel electroconductive scaffolds. 5. Living and non-living materials In addition to the wider application of natural biomaterials, designing, synthesis and testing of novel biomaterials for bioprinting is critically important. Indeed, there is a need to develop both more effective and more biocompatible biofabrication processes. In this area, material features are some of the most important issues, since a material suited to a particular fabrication method can, on the one hand, enhance the fabrication ability and, on the other hand, influence cell fate. In this latter aim, biofunctionalization by bioactive molecules and humoral factors can help in controlling adhesion, migration, proliferation, and differentiation of living cells [ 25 ] as well as in promoting tissue development (including the formation of characteristic organ microstructures and induction of capillary vessels). This orientation was in particular discussed by Nakamura during the conference [ 26 ]. Design specification is then a first and critical step on the way to developing and testing tailored bioprocessible and biomimetic biomaterials for bioprinting. Thus, broader participation of biomaterial scientists and chemical engineers in bioprinting and biofabrication research and conferences is highly desirable. Towards this aim, an interesting way for screening biomaterial and cell-material interactions, the so-called 'materiomics', was proposed by van Blitterswijk (Twente University, NL) [ 20 ]. Such study for exploring safe or biofunctional materials must contribute to the future development of biofabrication and tissue processing technologies. In several talks given by Nakayama (Fukuoka University, Japan), van Blitterswijk, Mironov and Forgacs (University Missouri, USA), it was proposed that living tissues be used as building blocks for printing 3D functional living tissue constructs. This emerging modular [ 27 ] or bottom-up approach was discussed at the conference and was also recently presented in an invited Leading Opinion Paper in the journal Biomaterials . It is interesting that the Editor-in-Chief, Professor D F Williams, in the paper 'On the nature of biomaterials' [ 28 ] wrote: 'Mironov et al consider organ printing to be the layer-by-layer additive robotic fabrication of 3D functional living tissues and organ constructs [ 29 ]. Mironov argues ... that tissue engineering may be better served by a solid biodegradable scaffold-free process. This position is predicated on the assumption that tissues and organs are self-organizing systems and that they normally undergo biological self-assembly and organization without any external influence in the form of instructive, supporting and directing templates or solid scaffolds. There is obviously some way to go before such a paradigm could be translated into a practical reality, but many steps have been taken. It might seem at first sight that if tissue engineering can be achieved by self-assembly of tissue components without the need for conventional solid materials, biomaterials would have no further role. In line with many earlier statements in this essay, I would consider the self-assembled tissue to be an engineered construct and, therefore, a biomaterial in its own right'. Thus, the leading biomaterial expert suggested considering living tissue blocks as biomaterials. Whether this is a real paradigm shift in biomaterial science and tissue engineering associated with emerging bioprinting technology, or just a question of semantics, remains to be seen. Several conference participants strongly believe that it is a paradigm shift. However, the real issue, as Williams outlined, is a translation of this new paradigm into practical reality. 6. The value of mathematical modeling and computer simulation Realization of rapid prototyping technology is impossible without computer science and the corresponding software. Acquisition of clinical images using modern imaging modalities and transforming them into computer-aided design (CAD) and STL files are important and essential steps in the bioprinting process as was well illustrated in Sun's (Drexel University, USA) state-of-the-art review [ 30 ]. However, existing commercial software is not flexible enough for biological applications especially for designing blueprints for soft 3D organs. For example, as was demonstrated in the talk about organ printing, bioprinted tissues undergo processes of tissue fusion and associated contraction and remodeling of printed constructs. The power of mathematical modeling in predicting post-printing tissue remodeling has also been illustrated in talks given by Forgacs' group (University of Missouri, USA). Mathematical modeling could be also used for prediction kinetics of cell seeding, tissue ingrowth, oxygenation and vascularization of bioprinted tissue constructs. New, more sophisticated and more flexible software, capable of incorporating experimentally estimated coefficients of tissue retraction, compaction and remodeling must be developed. This work is critical for advancing bioprinting technology and organizers of future bioprinting conferences must make a special effort to attract more specialists in mathematical computer simulation and computer to print a human organ conference participants were very about the potential of bioprinting technology to functional human organs. The was that it is a highly but long-term, It was also that without the engineering of an vascular 3D bioprinted tissue constructs will not However, in at one talk a was to how a complex 3D human organ such as a could be The group from the University of USA) and University USA) presented a approach to bioprinting a functional organ It obviously has a way to go and a must be for practical of this many essential of future organ printing technology are already in For example, the group presentation as well as Forgacs' group presentations demonstrated that building a vascular is a realistic and This was also by (University of USA) presented applications of in structures with human cells [ ] and Boland presented on printing of biomaterials and cells for capillary constructs [ ]. new bioprinting in vivo One of the main of this conference was the that in vivo bioprinting is many groups discussed the possibility of this the was that at it is just science However, for applications when there is no need for bioprinting in vivo can be a realistic The first at bioprinting in vivo was presented by the group [ 7 ]. One of the of this paper discussed the presented at the conference with the of one of the leading rapid prototyping and during this discussion the of a robotic clinical was as a potential Whether the clinical bioprinting will one the sophisticated robotic remains to be seen. of The of of University and a leading expert in recently wrote: is no such as a science There is only science If this is then one we can printing a human in a using the clinical bioprinting with a demonstrated in the . this in vivo bioprinting will be and how it will work but it is safe to at that bioprinting will be used and that the future will have more sophisticated than just the and of a as the modern robotic is since the First International Workshop on Bioprinting and Biopatterning held at the University of Manchester (UK) in the bioprinting scientific community has been now bringing together physicists, biologists and Consequently, and to the practical of the growing for special bioprinting sessions at traditional tissue engineering conferences as well as the very of this emerging it was proposed to the After discussion and considering the and a of 3B'09 the to form the on of organizers of and to also the Biofabrication and Bioassembly which would the new journal Biofabrication . It was also decided that The 5th International Conference on Bioprinting, Biofabrication and Bioassembly will be organized by Professor (Drexel University, USA) and Professor Gabor Forgacs (University of Missouri, USA) in Philadelphia, will be organized by Professor Makoto Nakamura in Toyama, and will be in Europe in or Italy, the is for Finally, it seems that the bioprinting field is a of growth and bioprinting is coming of age. It is essential that at future bioprinting and biofabrication conferences the established of the emerging bioprinting community to a for for novel technologies and as well as and discussion of existing and is This will that a and research community Fabien Guillemot the clusters Advanced Materials in Aquitaine, Materials in Bordeaux and Route des INSERM and the Aquitaine Regional for supporting organization of the 3B'09 conference. Moreover, work by the members of the and Makoto Nakamura the Bordeaux members for the of the 3B'09 conference. would also to to of the participants from the for this conference, to the of international for bioprinting and biofabrication Vladimir Mironov support from an Mironov Reis and Derby B 2006 a 12 Mironov 2005 The Second International Workshop on Bioprinting, Biopatterning and Bioassembly 5 International Conference on Bioprinting and Biofabrication (3B'09) Mironov Boland Forgacs and computer-aided jet-based 3D tissue engineering in 21 Materials printing cells Mironov et al a paradigm Biofabrication 1 Guillemot and Biofabrication 2 Sakaue Matsusaki and of 3D-micro tissue models for creation of tissue presented at International Conference on Bioprinting and Biofabrication (3B'09) Rainer and Biofabrication 2 Nakamura et al jet three-dimensional fabrication for biological tissue of by jet droplets for three tissue fabrication et al of a three-dimensional of cell supporting structures using hydrogel and state-of-the-art technology Guillemot F et al laser printing of cells and biomaterials for tissue engineering at and Guillemot F Biofabrication 2 and B Biofabrication 2 and Demirci Biofabrication 2 Wirth and Biofabrication 2 and of scaffolds using soft and Biomaterials 24 Ragaert and Biofabrication 2 Iwami Nakamura and Biofabrication 2 et al and developmental in tissues Biomaterials 30 I and Forgacs biology and tissue engineering 2005 scaffold design for tissue engineering 4 F and Forgacs vascular tissue engineering using bioprinting Biomaterials 30 and de for and Biofabrication 2 Nakamura K and Biofabrication 2 and tissue engineering biological tissues from the 5 Williams D F On the nature of biomaterials Biomaterials 30 Mironov et al tissue as building blocks Biomaterials 30 and The of printing and scaffold properties in the of a new Biofabrication 1 K and B Biofabrication 2 and Boland fabrication using printing technology Biomaterials 30
Source: Biofabrication
Language: English
Subfield: Biomedical Engineering
Field: Engineering
Domain: Physical Sciences
Open Access status: bronze
OpenAlex ID: W2006401406
